News Snapshot:
AstraZeneca Signs 1st COVID-19 Vaccine Supply Deal With Chinese Company By Reuters , Wire Service Content Aug. 6, 2020 By Reuters , Wire Service Content Aug. 6, 2020, at 4:08 a.m. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid Reuters By Roxanne Liu and Tony Munroe BEIJING (Reuters) - Shenzhen Kangtai Biological Products will produce AstraZeneca Plc's potential COVID-19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one...
